Bachem Holding AG
Bachem Holding AG (BCHMF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BCHMF · as of Jun 9, 2026
Key Statistics
Explore Bachem Holding AG Data
bchmf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
bchmf competitorsBCHMF
ARKAF
COIHF
COIHY
FUPEF
FUPPFStock Performance
Full HistoryAbout Bachem Holding AG
Bachem Holding AG is a global partner to pharmaceutical and biotechnology companies, supplying crucial products and services for every stage from early-stage research and clinical trials to full-scale…
what is bachem holding ag · bchmf stock overview · bachem holding ag company profile · who is bachem holding ag ceo · bchmf OTC · bachem holding ag headquarters · bachem holding ag business segments
About Stock Overview & Key Data
Bachem Holding AG (BCHMF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Mar 17, 2011. As of the latest trading session, BCHMF stock price is $91.23, with a market capitalization of $6.8B. The stock has returned +48.51% over the past 12 months and +50.77% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Bachem Holding AG stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Bachem Holding AG reported revenue of $695.4M and net income of $148.9M. For detailed data — including Bachem Holding AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bachem Holding AG (BCHMF) stock price is $91.23. The stock is traded on OTC under the ticker symbol BCHMF. The 52-week range is $60.51 – $94.62.